why choose us

First received: September 26, 2023

Clinical Trial: A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Lupus Nephritis

Study Type: INTERVENTIONAL


Official Title: An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis

Brief Summary: In this study, researchers will learn more about the use of felzartamab in people with active lupus nephritis, also known as LN. In people with LN, antibodies build up in the glomeruli of the kidneys. Antibodies are proteins in the blood used by the immune system to fight infection. Glomeruli are small filters that remove waste and extra fluid from the blood. This buildup leads to inflammation and damage to the kidneys.Kidney damage can lead to too much protein and blood leaking into the urine. High levels of…

Read more